Back to News
Market Impact: 0.32
BioAffinity Technologies Stock Surges Following Hong Kong Patent Grant
Source: benzinga.com
Patents & Intellectual PropertyHealthcare & Biotech
BioAffinity Technologies shares surged Thursday after receiving a key Hong Kong patent for its CyPath Lung diagnostic, strengthening intellectual-property protection for the product. BioAffinity warrants rose nearly 20% late Thursday, reflecting a positive investor response to the patent catalyst.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
BIAF0.82
More News
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Jefferies raises West Pharmaceutical stock price target on HVP growth
- Wells Fargo raises Abbvie stock price target to $340 on pipeline
- Wells Fargo raises Regeneron stock price target to $925 on execution
- Deutsche Bank downgrades Novartis stock rating to sell on valuation